From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy-Reference-Cited by-同舟云学术

From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy

Published:2022-11-10 Issue:5 Volume:113 Page:963-972
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Lemaire Vincent¹^ORCID,Bassen David²^ORCID,Reed Mike³,Song Roy⁴,Khalili Samira⁵,Lien Yi Ting (Kayla)¹^ORCID,Huang Lu⁶,Singh Aman P.⁷^ORCID,Stamatelos Spyros⁸,Bottino Dean⁷^ORCID,Hua Fei²^ORCID

Affiliation:

1. Genentech Inc. South San Francisco California USA

2. Applied BioMath Concord Massachusetts USA

3. Rosa & Co LLC San Carlos California USA

4. GSK Collegeville Pennsylvania USA

5. Takeda California, Inc. San Diego California USA

6. Bristol Myers Squibb Princeton New Jersey USA

7. Takeda Development Centers America Inc Cambridge Massachusetts USA

8. Bayer Whippany New Jersey USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2770

Reference43 articles.

1. Systems Pharmacology Models Can Be Used to Understand Complex Pharmacokinetic-Pharmacodynamic Behavior: An Example Using 5-Lipoxygenase Inhibitors

2. Screening system for drug-induced arrhythmogenic risk combining a patch clamp and heart simulator

3. The Hallmarks of Cancer

4. A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future

5. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements;Cancer Biomarkers;2024-08-04

2. Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs;Clinical Pharmacology & Therapeutics;2024-07-29

3. Moving the needle for oncology dose optimization: A call for action;Clinical and Translational Science;2024-06

4. Moving the needle for oncology dose optimization: A call for action;CPT: Pharmacometrics & Systems Pharmacology;2024-05-22

5. Moving the Needle for Oncology Dose Optimization: A Call for Action;Clinical Pharmacology & Therapeutics;2024-05-12